Christopher R. Chapple

Active 1987–2025

186
Papers
28,329
Citations
101
h-index
180
i10-index

Citations

Citations per year for Christopher R. Chapple1989: 6 citations1990: 18 citations1991: 4 citations1992: 7 citations1993: 15 citations1994: 15 citations1995: 34 citations1996: 14 citations1997: 26 citations1998: 39 citations1999: 22 citations2000: 29 citations2001: 37 citations2002: 42 citations2003: 43 citations2004: 49 citations2005: 78 citations2006: 109 citations2007: 85 citations2008: 93 citations2009: 92 citations2010: 74 citations2011: 116 citations2012: 175 citations2013: 186 citations2014: 129 citations2015: 113 citations2016: 80 citations2017: 116 citations2018: 97 citations2019: 517 citations2020: 571 citations2021: 471 citations2022: 272 citations2023: 287 citations2024: 442 citations2025: 121 citations2026: 4 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,091 citing papers, 20.7% of this breakdownUnited Kingdom: 651 citing papers, 12.3% of this breakdownItaly: 311 citing papers, 5.9% of this breakdownChina: 257 citing papers, 4.9% of this breakdownGermany: 249 citing papers, 4.7% of this breakdownNetherlands: 241 citing papers, 4.6% of this breakdownCanada: 224 citing papers, 4.2% of this breakdownJapan: 175 citing papers, 3.3% of this breakdownFrance: 168 citing papers, 3.2% of this breakdownAustralia: 129 citing papers, 2.4% of this breakdownBelgium: 124 citing papers, 2.4% of this breakdownSpain: 124 citing papers, 2.4% of this breakdown
0%20.7%Other 29%

Fields

  • Medicine90.1%
  • Biochemistry, Genetics and Molecular Biology4.2%
  • Neuroscience2.2%
  • Materials Science0.5%
  • Health Professions0.5%
  • Engineering0.4%
  • Other2.1%

Topics

  • Urinary Bladder and Prostate Research19.9%
  • Pelvic floor disorders treatments16.6%
  • Urinary Tract Infections Management6.8%
  • Urological Disorders and Treatments3.9%
  • Prostate Cancer Diagnosis and Treatment3.9%
  • Sexual function and dysfunction studies3.4%
  • Other45.5%

Coauthors

All papers

Open in search
  1. A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment

    Authors: , , , , , , , , , , - European Urology 2019 cited by 425

  2. Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021

    Authors: , , , , , , , - European Urology 2021 cited by 220

  3. The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study

    Authors: , , , , , , , , , , - British Journal of Urology 2009 cited by 793

  4. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder

    Authors: , , , , , , , , , , - British Journal of Pharmacology 2006 cited by 632

  5. Detrusor Underactivity and the Underactive Bladder: A New Clinical Entity? A Review of Current Terminology, Definitions, Epidemiology, Aetiology, and Diagnosis

    Authors: , , , , , , , , - European Urology 2013 cited by 374

  6. Prospective, Randomized, Multinational Study of Prostatic Urethral Lift Versus Transurethral Resection of the Prostate: 12-month Results from the BPH6 Study

    Authors: , , , , , , , , , , , , - European Urology 2015 cited by 253

  7. Efficacy and Tolerability of Mirabegron Compared with Antimuscarinic Monotherapy or Combination Therapies for Overactive Bladder: A Systematic Review and Network Meta-analysis

    Authors: , , , , , , , - European Urology 2018 cited by 222

  8. Fourth international consultation on incontinence recommendations of the international scientific committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , S. Tekgul, J.W. Thüroff, Andrea Tubaro, David B. Vodušek, Alan Wein, Jean‐Jacques Wyndaele - Neurourology and Urodynamics 2009 cited by 1,092

  9. Mirabegron in overactive bladder: A review of efficacy, safety, and tolerability

    Authors: , , , , - Neurourology and Urodynamics 2013 cited by 296

  10. Prostatic urethral lift vs transurethral resection of the prostate: 2‐year results of the BPH 6 prospective, multicentre, randomized study

    Authors: , , , , , , , , , , , - British Journal of Urology 2016 cited by 211

  11. Is there a link between overactive bladder and the metabolic syndrome in women? A systematic review of observational studies

    Authors: , , , , , , , , , , , , - International Journal of Clinical Practice 2014 cited by 107

  12. Pelvic Organ Prolapse Quantification System (POP-Q) - a new era in pelvic prolapse staging.

    Authors: , , , , - 2011 cited by 321

  13. International Continence Society consensus on the diagnosis and treatment of nocturia

    Authors: , , , , , , , , , , - Neurourology and Urodynamics 2019 cited by 136

  14. Male Lower Urinary Tract Symptoms and Cardiovascular Events: A Systematic Review and Meta-analysis

    Authors: , , , , , , , , , , , - European Urology 2016 cited by 124

  15. Complications related to use of mesh implants in surgical treatment of stress urinary incontinence and pelvic organ prolapse: infection or inflammation?

    Authors: , , , - World Journal of Urology 2019 cited by 88

  16. Predicting Prostate Surgery Outcomes from Standard Clinical Assessments of Lower Urinary Tract Symptoms To Derive Prognostic Symptom and Flowmetry Criteria

    Authors: , , , , , , , , , , , - European Urology Focus 2023 cited by 27

  17. OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial

    Authors: , , , , , , , , - European Urology 2013 cited by 408

  18. The impact of overactive bladder on mental health, work productivity and health‐related quality of life in the UK and Sweden: results from EpiLUTS

    Authors: , , , , , - British Journal of Urology 2011 cited by 286

  19. Landmarks in vaginal mesh development: polypropylene mesh for treatment of SUI and POP

    Authors: , , , - Nature Reviews Urology 2019 cited by 67

  20. Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE)

    Authors: , , , , , , , , , , , , - European Urology 2016 cited by 183

  21. Pelvic Complications After Prostate Cancer Radiation Therapy and Their Management: An International Collaborative Narrative Review

    Authors: , , , , , , , , , - European Urology 2018 cited by 99

  22. Diagnostic Assessment of Lower Urinary Tract Symptoms in Men Considering Prostate Surgery: A Noninferiority Randomised Controlled Trial of Urodynamics in 26 Hospitals

    Authors: , , , , , , , , , , , - European Urology 2020 cited by 74

  23. A Systematic Review of Surgical interventions for the Treatment of Bladder Pain Syndrome/Interstitial Cystitis

    Authors: , , , , , - European Urology Focus 2020 cited by 61

  24. Updated Systematic Review and Meta-analysis of the Comparative Data on Colposuspensions, Pubovaginal Slings, and Midurethral Tapes in the Surgical Treatment of Female Stress Urinary Incontinence

    Authors: , , , , , , - European Urology 2017 cited by 286